Metabolic flexibility and cell hierarchy in metastatic cancer.

Cancer is characterized by disturbed homeostasis of self-renewing cell populations, and their ability to seed and grow in multiple microenvironments. This overarching cellular property of metastatic cancer emerges from the contentious cancer stem cell hypothesis that underpins the more generic hallmarks of cancer (Hanahan and Weinberg, 2000) and its subsequent add-ons. An additional characteristic, metabolic flexibility, is related to concepts developed by Warburg and to subsequent work by mid 20th century biochemists who elucidated the bioenergetic workings of mitochondria. Metabolic flexibility may circumvent limitations inherent in the increasingly popular but erroneous view that aerobic glycolysis is a universal property of cancer cells. Cancer research in the second half of the 20th century was largely the domain of geneticists and molecular biologists using reductionist approaches. Integrated approaches that address cancer cell hierarchy and complexity, and how cancer cells adapt their metabolism according to their changing environment are now beginning to emerge, and these approaches promise to address the poor mortality statistics of metastatic cancer.

[1]  S. Gottschalk,et al.  Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells , 2004, Clinical Cancer Research.

[2]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[3]  T. Brand.  Heavy metal prosthetic groups and enzyme action , 1950 .

[4]  Emma Saavedra,et al.  Energy metabolism in tumor cells , 2007, The FEBS journal.

[5]  P. Magistretti,et al.  Activity‐dependent regulation of energy metabolism by astrocytes: An update , 2007, Glia.

[6]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[8]  C. Godinot,et al.  Actuality of Warburg’s views in our understanding of renal cancer metabolism , 2007, Journal of bioenergetics and biomembranes.

[9]  P. Pedersen,et al.  Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells. , 1984, Cancer research.

[10]  J. Foker,et al.  Aerobic glycolysis during lymphocyte proliferation , 1976, Nature.

[11]  M. Müller,et al.  ATP-producing and consuming processes of Ehrlich mouse ascites tumor cells in proliferating and resting phases. , 1991, Experimental cell research.

[12]  G. Semenza,et al.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.

[13]  S. Kishigami,et al.  Potential existence of stem cells with multiple differentiation abilities to three different germ lineages in mouse neurospheres. , 2009, Stem cells and development.

[14]  C. Thompson,et al.  Uncoupling protein‐2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis‐derived pyruvate utilization , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  N. Denko,et al.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.

[16]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[17]  Siqing Shan,et al.  The pervasive presence of fluctuating oxygenation in tumors. , 2008, Cancer research.

[18]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[19]  L. Gladden.  Lactate metabolism: a new paradigm for the third millennium , 2004, The Journal of physiology.

[20]  K. Black,et al.  Glioma stem cell research for the development of immunotherapy. , 2010, Neurosurgery clinics of North America.

[21]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[22]  Keshav K. Singh,et al.  Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion , 2008, Cancer biology & therapy.

[23]  M. Berridge,et al.  Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines. , 2007, Biochimica et biophysica acta.

[24]  M. Dean,et al.  Targeted therapy for cancer stem cells: the patched pathway and ABC transporters , 2007, Oncogene.

[25]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[26]  M. Berridge,et al.  Mitochondrial gene-knockout (rho0) cells: a versatile model for exploring the secrets of trans-plasma membrane electron transport. , 2004, BioFactors.

[27]  Silvia Mangia,et al.  The in vivo neuron‐to‐astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation , 2009, Journal of neurochemistry.

[28]  M. Clarke,et al.  Identification of pancreatic cancer stem cells. , 2007, Cancer research.

[29]  M. King,et al.  Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. , 1989, Science.

[30]  M. Guppy,et al.  Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.

[31]  T. Ishikawa,et al.  Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics. , 2009, Journal of experimental therapeutics & oncology.

[32]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[33]  G. Semenza,et al.  HIF-1 mediates the Warburg effect in clear cell renal carcinoma , 2007, Journal of bioenergetics and biomembranes.

[34]  K. Jauch,et al.  Cancer stem cells: how can we target them? , 2008, Current medicinal chemistry.

[35]  P. Robson,et al.  Transcriptional Regulation of Nanog by OCT4 and SOX2* , 2005, Journal of Biological Chemistry.

[36]  R. Schreiber,et al.  The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.

[37]  J. Hacia,et al.  mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft , 2008, BMC Genomics.

[38]  S. Vannucci,et al.  Supply and Demand in Cerebral Energy Metabolism: The Role of Nutrient Transporters , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  O. Warburg.  On the origin of cancer cells. , 1956, Science.

[40]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[41]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[42]  Frederico A. C. Azevedo,et al.  Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.

[43]  K. Black,et al.  Antigen‐Specific T‐Cell Response from Dendritic Cell Vaccination Using Cancer Stem‐Like Cell‐Associated Antigens , 2009, Stem cells.

[44]  P. Magistretti,et al.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Andreeff,et al.  The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. , 2008, Cancer research.

[46]  D. Levine,et al.  Mitochondrial gene knockout HL60rho0 cells show preferential differentiation into monocytes/macrophages. , 2005, Leukemia research.

[47]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[48]  P. Rich.  Chemiosmotic coupling: The cost of living , 2003, Nature.

[49]  M. Berridge,et al.  Effects of mitochondrial gene deletion on tumorigenicity of metastatic melanoma: reassessing the Warburg effect. , 2010, Rejuvenation research.

[50]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[51]  K. Brand.  Aerobic Glycolysis by Proliferating Cells: Protection against Oxidative Stress at the Expense of Energy Yield , 1997, Journal of bioenergetics and biomembranes.

[52]  N. Denko,et al.  Hypoxia, HIF1 and glucose metabolism in the solid tumour , 2008, Nature Reviews Cancer.

[53]  Y. Yang,et al.  Depletion of mitochondrial DNA by ethidium bromide treatment inhibits the proliferation and tumorigenesis of T47D human breast cancer cells. , 2007, Toxicology letters.

[54]  M. Andreeff,et al.  Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. , 2009, Cancer research.

[55]  M. Berridge,et al.  Cell surface oxygen consumption by mitochondrial gene knockout cells. , 2004, Biochimica et biophysica acta.

[56]  R. Moreno-Sánchez,et al.  HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. , 2009, Mini reviews in medicinal chemistry.

[57]  H. Majima,et al.  Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. , 2007, Mitochondrion.

[58]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[59]  I. Tannock,et al.  The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. , 1998, British Journal of Cancer.